Anatomic Malformations of the Middle and Inner Ear in 22q11.2 Deletion Syndrome: Case Series and Literature Review

References

1. 1.↵
   2. Kobrynski LJ,
   3. Sullivan KE

   . Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007;370:1443–52 doi:10.1016/S0140-6736(07)61601-8 pmid:17950858

   CrossRefPubMedWeb of Science
2. 2.↵
   2. McDonald-McGinn DM,
   3. Sullivan KE,
   4. Marino B, et al

   . 22q11.2 deletion syndrome. Nat Rev Dis Primers 2015;1:15071 doi:10.1038/nrdp.2015.71 pmid:27189754

   CrossRefPubMed
3. 3.↵
   2. Robin NH,
   3. Shprintzen RJ

   . Defining the clinical spectrum of deletion 22q11.2. J Pediatr 2005;147:90–96 doi:10.1016/j.jpeds.2005.03.007 pmid:16027702

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Dyce O,
   3. McDonald-McGinn DM,
   4. Kirschner RE, et al

   . Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch Otolaryngol Head Neck Surg 2002;128:1408–12 doi:10.1001/archotol.128.12.1408 pmid:12479730

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Digilio MC,
   3. Pacifico C,
   4. Tieri L, et al

   . Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol 1999;33:329–33 doi:10.3109/03005369909090116 pmid:10890147

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Ford LC,
   3. Sulprizio SL,
   4. Rasgon BM

   . Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients. Laryngoscope 2000;110:362–67 doi:10.1097/00005537-200003000-00006 pmid:10718420

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Reyes MR,
   3. LeBlanc EM,
   4. Bassila MK

   . Hearing loss and otitis media in velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol 1999;47:227–33 doi:10.1016/S0165-5876(98)00180-3 pmid:10321777

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Persson C,
   3. Friman V,
   4. Óskarsdóttir S, et al

   . Speech and hearing in adults with 22q11.2 deletion syndrome. Am J Med Genet A 2012;158A:3071–79 doi:10.1002/ajmg.a.35589 pmid:23165987

   CrossRefPubMed
9. 9.↵
   2. Van Eynde C,
   3. Swillen A,
   4. Lambeens E, et al

   . Prevalence and nature of hearing loss in 22q11.2 deletion syndrome. J Speech Lang Hear Res 2016;59:583–89 doi:10.1044/2015_JSLHR-H-15-0098 pmid:27249537

   CrossRefPubMed
10. 10.↵
    2. Weir FW,
    3. Wallace SA,
    4. White DR, et al

    . Otologic and audiologic outcomes in pediatric patients with velo-cardio-facial (22q11 deletion) syndrome. Otol Neurotol 2016;38:73–78 doi:10.1097/MAO.0000000000001226 pmid:27956721

    CrossRefPubMed
11. 11.↵
    2. Zarchi O,
    3. Attias J,
    4. Raveh E, et al

    . A comparative study of hearing loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. J Pediatr 2011;158:301–06 doi:10.1016/j.jpeds.2010.07.056 pmid:20846670

    CrossRefPubMed
12. 12.↵
    2. Junior AT,
    3. Haetinger RG,
    4. Silva FL, et al

    . Middle and inner ear malformations in two cases of velocardiofacial syndrome. Intl Arch Otorhinolaryngol 2009;13:83–86
13. 13.↵
    2. Devriendt K,
    3. Swillen A,
    4. Schatteman I, et al

    . Middle and inner ear malformations in velocardiofacial syndrome. Am J Med Genet A 2004;131:225–26 pmid:15389775

    PubMed
14. 14.↵
    2. Cunningham ML,
    3. Perry RJ,
    4. Eby PR, et al

    . Primary pulmonary dysgenesis in velocardiofacial syndrome: a second patient. Am J Med Genet A 2003;121A:177–79 doi:10.1002/ajmg.a.20142 pmid:12910501

    CrossRefPubMed
15. 15.↵
    2. Hopsu E,
    3. Markkola A,
    4. Pitkäranta A

    . Labyrinthine malformation in the 22q11.2 deletion syndrome. Clin Dysmorphol 2007;16:67–68 doi:10.1097/MCD.0b013e328010d0a4 pmid:17159521

    CrossRefPubMed
16. 16.↵
    2. Loos E,
    3. Verhaert N,
    4. Willaert A, et al

    . Malformations of the middle and inner ear on CT imaging in 22q11 deletion syndrome. Am J Med Genet A 2016;170:2975–83 doi:10.1002/ajmg.a.37872 pmid:27604838

    CrossRefPubMed
17. 17.↵
    2. Fuchs JC,
    3. Zinnamon FA,
    4. Taylor RR, et al

    . Hearing loss in a mouse model of 22q11.2 deletion syndrome. PLoS One 2013;8:e80104 doi:10.1371/journal.pone.0080104 pmid:24244619

    CrossRefPubMed
18. 18.↵
    2. Funke B,
    3. Epstein JA,
    4. Kochilas LK, et al

    . Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects. Hum Mol Genet 2001;10:2549–56 doi:10.1093/hmg/10.22.2549 pmid:11709542

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Vitelli F,
    3. Viola A,
    4. Morishima M, et al

    . TBX1 is required for inner ear morphogenesis. Hum Mol Genet 2003;12:2041–48 doi:10.1093/hmg/ddg216 pmid:12913075

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Arnold JS,
    3. Braunstein EM,
    4. Ohyama T, et al

    . Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Hum Mol Genet 2006;15:1629–39 doi:10.1093/hmg/ddl084 pmid:16600992

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Purcell D,
    3. Johnson J,
    4. Fischbein N, et al

    . Establishment of normative cochlear and vestibular measurements to aid in the diagnosis of inner ear malformations. Otolaryngol Head Neck Surg 2003;128:78–87 doi:10.1067/mhn.2003.51 pmid:12574763

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Monsell EM

    . Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss: American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:186–87 doi:10.1016/S0194-5998(95)70103-6 pmid:7675477

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Bohm LA,
    3. Zhou TC,
    4. Mingo TJ, et al

    . Neuroradiographic findings in 22q11.2 deletion syndrome. Am J Med Genet A 2017;173:2158–65 doi:10.1002/ajmg.a.38304 pmid:28577347

    CrossRefPubMed
24. 24.↵
    2. Jiramongkolchai P,
    3. Kumar MS,
    4. Chinnadurai S, et al

    . Prevalence of hearing loss in children with 22q11.2 deletion syndrome. Int J Pediatr Otorhinolaryngol 2016;87:130–33 doi:10.1016/j.ijporl.2016.06.005 pmid:27368459

    CrossRefPubMed
25. 25.↵
    1. Lemmerling M,
    2. De Foer B

    2. Casselman JW,
    3. Delanote J,
    4. Kuhweide R, et al

    . Congenital malformations of the temporal bone. In: Lemmerling M, De Foer B, eds. Temporal Bone Imaging. Berlin: Springer-Verlag; 2015
26. 26.↵
    2. Rodriguez K,
    3. Shah RK,
    4. Kenna M

    . Anomalies of the middle and inner ear. Otolaryngol Clin North Am 2007;40:81–96, vi doi:10.1016/j.otc.2006.10.006 pmid:17346562

    CrossRefPubMed
27. 27.↵
    2. Lim R,
    3. Brichta AM

    . Anatomical and physiological development of the human inner ear. Hear Res 2016;338:9–21 doi:10.1016/j.heares.2016.02.004 pmid:26900072

    CrossRefPubMed
28. 28.↵
    2. Jackler R,
    3. Luxford W,
    4. House W

    . Cochlear malformations of the inner ear: a classification based on embryogenesis. Laryngoscope 1987;97:2–14 pmid:3821363

    PubMedWeb of Science
29. 29.↵
    2. Jeffery N,
    3. Spoor F

    . Prenatal growth and development of the modern human labyrinth. J Anat 2004;204:71–92 doi:10.1111/j.1469-7580.2004.00250.x pmid:15032915

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Matsunaga T,
    3. Hirota E

    . Familial lateral semicircular canal malformation with external and middle ear abnormalities. Am J Med Genet A 2003;116A:360–67 doi:10.1002/ajmg.a.10866 pmid:12522792

    CrossRefPubMed
31. 31.↵
    2. Johnson J,
    3. Lalwani AK

    . Sensorineural and conductive hearing loss associated with lateral semicircular canal malformation. Laryngoscope 2000;110:1673–79 doi:10.1097/00005537-200010000-00019 pmid:11037823

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Michel G,
    3. Espitalier F,
    4. Delemazure AS, et al

    . Isolated lateral semicircular canal aplasia: functional consequences. Eur Ann Otorhinolaryngol Head Neck Dis 2016;133:199–201 doi:10.1016/j.anorl.2015.09.002 pmid:26387614

    CrossRefPubMed
33. 33.↵
    2. Oskarsdóttir S,
    3. Belfrage M,
    4. Sandstedt E, et al

    . Disabilities and cognition in children and adolescents with 22q11 deletion syndrome. Dev Med Child Neurol 2005;47:177–84 doi:10.1017/S0012162205000320 pmid:15739722

    CrossRefPubMed
34. 34.↵
    2. Roizen NJ,
    3. Higgins AM,
    4. Antshel KM, et al

    . 22q11.2 deletion syndrome: are motor deficits more than expected for IQ level? J Pediatr 2010;157:658–61 doi:10.1016/j.jpeds.2010.04.073 pmid:20646714

    CrossRefPubMed
35. 35.↵
    2. Sobin C,
    3. Monk SH,
    4. Kiley-Brabeck K, et al

    . Neuromotor deficits in children with the 22q11 deletion syndrome. Mov Disord 2006;21:2082–89 doi:10.1002/mds.21103 pmid:16991148

    CrossRefPubMed
36. 36.↵
    2. Van Aken K,
    3. De Smedt B,
    4. Van Roie A, et al

    . Motor development in school-aged children with 22q11 deletion (velocardiofacial/DiGeorge syndrome). Dev Med Child Neurol 2007;49:210–13 doi:10.1111/j.1469-8749.2007.00210.x pmid:17355478

    CrossRefPubMed
37. 37.↵
    2. Roizen NJ,
    3. Antshel KM,
    4. Fremont W, et al

    . 22q11.2DS deletion syndrome: developmental milestones in infants and toddlers. J Dev Behav Pediatr 2007;28:119–24 doi:10.1097/01.DBP.0000267554.96081.12 pmid:17435462

    CrossRefPubMed
38. 38.↵
    2. Gerdes M,
    3. Solot C,
    4. Wang PP, et al

    . Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 1999;85:127–33 pmid:10406665

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Swillen A,
    3. Devriendt K,
    4. Legius E, et al

    . The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns 1999;10:79–88 pmid:10191433

    PubMedWeb of Science
40. 40.↵
    2. Sennaroglu L,
    3. Saatci I

    . A new classification for cochleovestibular malformations. Laryngoscope 2002;112:2230–41 doi:10.1097/00005537-200212000-00019 pmid:12461346

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Raft S,
    3. Nowotschin S,
    4. Liao J, et al

    . Suppression of neural fate and control of inner ear morphogenesis by Tbx1. Development 2004;131:1801–12 doi:10.1242/dev.01067 pmid:15084464

    Abstract/FREE Full Text
42. 42.↵
    2. Braunstein EM,
    3. Monks DC,
    4. Aggarwal VS, et al

    . Tbx1 and Brn4 regulate retinoic acid metabolic genes during cochlear morphogenesis. BMC Dev Biol 2009;9:31 doi:10.1186/1471-213X-9-31 pmid:19476657

    CrossRefPubMed
43. 43.↵
    2. Monks DC,
    3. Morrow BE

    . Identification of putative retinoic acid target genes downstream of mesenchymal Tbx1 during inner ear development. Dev Dyn 2012;241:563–73 doi:10.1002/dvdy.23731 pmid:22275070

    CrossRefPubMed
44. 44.↵
    2. Jerome LA,
    3. Papaioannou VE

    . DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 2001;27:286–91 doi:10.1038/85845 pmid:11242110

    CrossRefPubMedWeb of Science
45. 45.↵
    2. Moreano E,
    3. Paparella M,
    4. Zelterman D, et al

    . Prevalence of carotid canal dehiscence in the human middle ear: a report of 1000 temporal bones. Laryngoscope 1994;104:612–18 doi:10.1002/lary.5541040515 pmid:8189992

    CrossRefPubMed
46. 46.↵
    2. Wang CH,
    3. Shi ZP,
    4. Liu DW, et al

    . High computed tomographic correlations between carotid canal dehiscence and high jugular bulb in the middle ear. Audiol Neurotol 2011;16:106–12 doi:10.1159/000314755 pmid:20606423

    CrossRefPubMed
47. 47.↵
    2. Derbent M,
    3. Yilmaz Z,
    4. Baltaci V, et al

    . Chromosome 22q11.2 deletion and phenotypic features in 30 patients with conotruncal heart defects. Am J Med Genet A 2003;116A:129–35 doi:10.1002/ajmg.a.10832 pmid:12494430

    CrossRefPubMed
48. 48.↵
    2. Digilio MC,
    3. McDonald-McGinn DM,
    4. Heike C, et al

    . Three patients with oculo-auriculo-vertebral spectrum and microdeletion 22q11.2. Am J Med Genet A 2009;149A:2860–64 doi:10.1002/ajmg.a.33034 pmid:19890921

    CrossRefPubMed
49. 49.↵
    2. Sleifer P,
    3. Gorsky Nde S,
    4. Goetze TB, et al

    . Audiological findings in patients with oculo-auriculo-vertebral spectrum. Int Arch Otorhinolaryngol 2015;19:5–9 doi:10.1055/s-0034-1390137 pmid:25992144

    CrossRefPubMed
50. 50.↵
    2. Baldini A

    . Dissecting contiguous gene defects: TBX1. Curr Opin Genet Dev 2005;15:279–84 doi:10.1016/j.gde.2005.03.001 pmid:15917203

    CrossRefPubMedWeb of Science